Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Qualitative Health Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hopwood, M.
Right arrow Articles by Treloar, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hopwood, M.
Right arrow Articles by Treloar, C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Hepatitis C
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Experience of Interferon-Based Treatments for Hepatitis C Infection

Max Hopwood

National Centre in HIV Social Research, University of New South Wales, Sydney, Australia

Carla Treloar

National Centre in HIV Social Research, University of New South Wales, Sydney, Australia

Clinical trials of interferon-based treatments for hepatitis C infection show decrements in patients’ health-related quality of life due to side effects of therapy. The impact of side effects on patients’ overall quality of life still remains unclear. To explore this issue, the authors interviewed people living in New South Wales, Australia, who had undergone treatment for hepatitis C. Their aim in this article is to report participants’ experiences of treatment side effects. In Australia, this information is important, because a new interferon-based regimen has been adopted as the mainstay of hepatitis C treatment, and it is predicted that many more people will seek treatment. The authors argue for further qualitative research to enhance knowledge of the impact of this therapy.

Key Words: hepatitis C treatment • interferon • side effects • quality of life

Qualitative Health Research, Vol. 15, No. 5, 635-646 (2005)
DOI: 10.1177/1049732304273932
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Qual Health ResHome page
C. Treloar and T. Rhodes
The Lived Experience of Hepatitis C and its Treatment Among Injecting Drug Users: Qualitative Synthesis
Qual Health Res, September 1, 2009; 19(9): 1321 - 1334.
[Abstract] [PDF]

Home page
 J Health PsycholHome page
M. Hopwood and C. Treloar
Resilient Coping: Applying Adaptive Responses to Prior Adversity during Treatment for Hepatitis C Infection
J Health Psychol, January 1, 2008; 13(1): 17 - 27.
[Abstract] [PDF]